|
Comprehensive
Our diverse range of services provides our
pharmaceutical and biotechnology sponsors with an unparalleled ability
to assess novel therapeutic agents in a comprehensive fashion.
Cutting Edge
Biospective's scientists utilize the most
sophisticated analysis methods available today. Our quantitative
structural, functional, and molecular measures provide unrivalled
sensitivity for detecting therapeutic effects in both CNS disease and
oncology studies.
Translatable
Only Biospective bridges the gap between
pre-clinical studies and early-phase clinical trials. Our expert team
of scientists works closely with our clients to design biodistribution,
mechanism-of-action, and efficacy studies that increase the chances of
success.
High Quality
Biospective adheres to
internationally-accepted practices to ensure the highest possible
quality, integrity, and reliability of
our studies. Our pre-clinical studies are conducted in the spirit of
GLP and clinical studies follow ICH GCP principles.
|